S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:XRAY

DENTSPLY SIRONA (XRAY) Stock Forecast, Price & News

$37.75
+0.43 (+1.15%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$36.82
$37.82
50-Day Range
$36.38
$49.84
52-Week Range
$35.00
$68.82
Volume
1.62 million shs
Average Volume
2.30 million shs
Market Capitalization
$8.13 billion
P/E Ratio
22.34
Dividend Yield
1.34%
Beta
0.94
30 days | 90 days | 365 days | Advanced Chart
Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.

DENTSPLY SIRONA logo

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces. The company also provides dental CAD/CAM products, digital impressions intraoral scanners, mills, and services; and orthodontic products, including high frequency vibration technology device under the name VPro, dentist-directed clear aligner solutions under the name SureSmile, and direct-to-consumer clear aligner solutions under the name Byte; dental implant products, bone regenerative and restorative solutions, and educational programs; and urology catheters and other healthcare-related consumable products. In addition, it offers endodontic products comprising endodontic instruments and materials, drills, filers, sealers, irrigation needles, and other tools or single-use solutions; restorative products that include dental prosthetics, such as artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products; small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers; and dental supplies, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Dental equipment & supplies
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:XRAY
CUSIP
24903010
Employees
15,000
Year Founded
2016

Sales & Book Value

Annual Sales
$4.25 billion
Cash Flow
$4.48 per share
Book Value
$22.77 per share

Profitability

Net Income
$421 million
Pretax Margin
11.77%

Debt

Price-To-Earnings

Miscellaneous

Free Float
213,815,000
Market Cap
$8.13 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 4/8 Dividend
3/24/2022
Dividend Payable
4/08/2022
Last Earnings
5/10/2022
Today
5/21/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

3.27 out of 5 stars

Medical Sector

4th out of 1,420 stocks

Dental Equipment & Supplies Industry

1st out of 6 stocks

Analyst Opinion: 4.2Community Rank: 4.3Dividend Strength: 4.2Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -













DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

Is DENTSPLY SIRONA a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last twelve months. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" DENTSPLY SIRONA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares.
View analyst ratings for DENTSPLY SIRONA
or view top-rated stocks.

Are investors shorting DENTSPLY SIRONA?

DENTSPLY SIRONA saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 2,780,000 shares, a decrease of 23.2% from the April 15th total of 3,620,000 shares. Based on an average trading volume of 2,440,000 shares, the days-to-cover ratio is presently 1.1 days. Approximately 1.3% of the shares of the company are short sold.
View DENTSPLY SIRONA's Short Interest
.

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for DENTSPLY SIRONA
.

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) released its quarterly earnings data on Tuesday, May, 10th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing the consensus estimate of $0.56 by $0.04. The medical instruments supplier had revenue of $9.67 billion for the quarter, compared to the consensus estimate of $982.05 million. DENTSPLY SIRONA had a trailing twelve-month return on equity of 11.63% and a net margin of 8.81%. The firm's revenue was up 841.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.72 EPS.
View DENTSPLY SIRONA's earnings history
.

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA announced a quarterly dividend on Thursday, March 3rd. Shareholders of record on Friday, March 25th will be paid a dividend of $0.125 per share on Friday, April 8th. This represents a $0.50 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date is Thursday, March 24th. This is an increase from DENTSPLY SIRONA's previous quarterly dividend of $0.11.
View DENTSPLY SIRONA's dividend history
.

Is DENTSPLY SIRONA a good dividend stock?

DENTSPLY SIRONA pays an annual dividend of $0.50 per share and currently has a dividend yield of 1.34%. DENTSPLY SIRONA has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of DENTSPLY SIRONA is 29.59%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 18.80% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.
View DENTSPLY SIRONA's dividend history.

What guidance has DENTSPLY SIRONA issued on next quarter's earnings?

DENTSPLY SIRONA issued an update on its FY 2022 earnings guidance on Tuesday, May, 17th. The company provided EPS guidance of $2.35-$2.55 for the period, compared to the consensus estimate of $2.77. The company issued revenue guidance of $4.10 billion-$4.20 billion, compared to the consensus revenue estimate of $4.23 billion.

What price target have analysts set for XRAY?

9 brokerages have issued 1 year price objectives for DENTSPLY SIRONA's shares. Their forecasts range from $46.00 to $67.00. On average, they anticipate DENTSPLY SIRONA's stock price to reach $51.00 in the next twelve months. This suggests a possible upside of 35.1% from the stock's current price.
View analysts' price targets for DENTSPLY SIRONA
or view top-rated stocks among Wall Street analysts.

Who are DENTSPLY SIRONA's key executives?
DENTSPLY SIRONA's management team includes the following people:
  • Mr. Jorge M. Gomez M.B.A., Exec. VP & CFO (Age 54, Pay $1.19M)
  • Mr. Walter Petersohn, Sr. VP & Chief Commercial Officer (Age 55, Pay $677.89k) (LinkedIn Profile)
  • Mr. John P. Groetelaars, Interim CEO & Director (Age 55)
  • Mr. Ranjit S. Chadha, Chief Accounting Officer (Age 52)
  • Mr. Cord Friedrich Staehler, Sr. VP of Digital Platforms & Solutions and CTO (Age 52)
  • Andrea Daley, VP of Investor Relations
  • Ms. Cheree Haswell Johnson, Sr. VP, Chief Legal Officer, Gen. Counsel & Sec. (Age 46)
  • Ms. Lisa M. Yankie, Sr. VP and Chief HR Officer & Communications (Age 53) (LinkedIn Profile)
  • Ms. Erania Brackett, Sr. VP & Chief Marketing Officer
  • Mr. Chidam Alagappa Chidambaram, Sr. VP & Chief Digital Officer (Age 55)
What is Don Casey's approval rating as DENTSPLY SIRONA's CEO?

105 employees have rated DENTSPLY SIRONA CEO Don Casey on Glassdoor.com. Don Casey has an approval rating of 70% among DENTSPLY SIRONA's employees.

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Boeing (BA), General Electric (GE), International Business Machines (IBM), Broadcom (AVGO), Comcast (CMCSA), Gilead Sciences (GILD) and Tesla (TSLA).

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.29%), BlackRock Inc. (11.18%), State Street Corp (4.42%), First Eagle Investment Management LLC (3.93%), Wellington Management Group LLP (2.55%) and Champlain Investment Partners LLC (2.54%). Company insiders that own DENTSPLY SIRONA stock include Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Lisa Yankie, Michael C Alfano, Walter Petersohn, William E Newell and Willie A Deese.
View institutional ownership trends for DENTSPLY SIRONA
.

Which major investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., New York State Common Retirement Fund, Invesco Ltd., Bank of New York Mellon Corp, State Street Corp, Teacher Retirement System of Texas, Canada Pension Plan Investment Board, and Allianz Asset Management GmbH. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Lisa Yankie, and Walter Petersohn.
View insider buying and selling activity for DENTSPLY SIRONA
or view top insider-selling stocks.

Which major investors are buying DENTSPLY SIRONA stock?

XRAY stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Wellington Management Group LLP, American Century Companies Inc., First Eagle Investment Management LLC, Ceredex Value Advisors LLC, Nuance Investments LLC, Panagora Asset Management Inc., and Cooke & Bieler LP. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Donald M Jr Casey, and Gregory T Lucier.
View insider buying and selling activity for DENTSPLY SIRONA
or or view top insider-buying stocks.

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $37.75.

How much money does DENTSPLY SIRONA make?

DENTSPLY SIRONA has a market capitalization of $8.13 billion and generates $4.25 billion in revenue each year. The medical instruments supplier earns $421 million in net income (profit) each year or $1.69 on an earnings per share basis.

How many employees does DENTSPLY SIRONA have?

DENTSPLY SIRONA employs 15,000 workers across the globe.

When was DENTSPLY SIRONA founded?

DENTSPLY SIRONA was founded in 2016.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at (844) 848-0137, via email at [email protected], or via fax at 302-655-5049.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.